YAO Qin, WANG Jingjing, LI Qian, et al. Placental Permeability of Escitalopram Based on Human Placental Extracorporeal Circulation Perfusion Model. [J]. (11):1306-1309(2022)
DOI:
YAO Qin, WANG Jingjing, LI Qian, et al. Placental Permeability of Escitalopram Based on Human Placental Extracorporeal Circulation Perfusion Model. [J]. (11):1306-1309(2022) DOI: 10.14009/j.issn.1672-2124.2022.11.005.
Placental Permeability of Escitalopram Based on Human Placental Extracorporeal Circulation Perfusion Model
摘要
目的:应用人胎盘体外循环灌注模型,对艾司西酞普兰进行胎盘透过性研究。方法:选择刚娩出的健康足月人胎盘,建立胎盘体外循环灌注模型,循环灌注3 h
OBJECTIVE: To probe into the placental permeability of escitalopram by human placental extracorporeal circulation perfusion model. METHODS: Healthy and full-term human placentas that had just been delivered were selected
the placental extracorporeal circulation perfusion model was established and circularly perfused for 3 h. During this period
samples were taken from the maternal pool and the fetal pool
and the pH
PO
2
β-human chorionic gonadotropin
glucose consumption
lactate production
fluid loss from the fetal pool
the concentrations of positive controls of antipyrine and escitalopram were detected to assess the placental transmission rates. RESULTS: In this study
158 human placental extracorporeal circulation perfusion models were performed
and 15 cases met the criteria for successful model establishment. After 3 h of circulation perfusion
the placental permeation rate of escitalopram was(9.09±2.80)% and the relative permeation rate was(23.35±4.37)%. CONCLUSIONS: Escitalopram can penetrate the placenta in small dose and lead to fetal exposure to escitalopram.
关键词
艾司西酞普兰胎盘转运体外人胎盘灌注模型
Keywords
EscitalopramPlacental transferExtracorporeal human placental circulation perfusion